AI continues to amaze – ChatGPT is now passing Wharton Business School exams, Microsoft and Google are doubling down in their AI efforts – and I’m as big a fan as anyone, but I want to talk about a technology that has been more under the radar, so to speak: ultrasound.
Ultrasound Direct Sound Printing. Credit: depositphotos/New Atlas
Yes, ultrasound.
Most of us have probably had an ultrasound at some point (especially if you’ve
been pregnant) and Dr. Eric Topel continues his years-long
quest to replace the ancient stethoscope technology with ultrasound, but if you
think ultrasound is just another nifty tool in the imaging toolbox, you’ve
missed a lot.
Let’s start with the coolest use I’ve seen: ultrasound
can be used for 3D printing. Inside
the body.
This news on this dates back to last April, when researchers from Concordia University published their findings in Nature (I found out about it last week). Instead of the more common “Additive Manufacturing” (AM) approach to 3D printing, these researchers use Direct Sound Printing (DSP).
The paper summarizes
their results: “To show unique future potentials of DSP, applications such as
RDP [Remote Distance Printing] for inside body bioprinting and direct nano particle
synthesizing and pattering by DSP for integrating localized surface plasmon
resonance with microfluidics chip are experimentally demonstrated.”
As lead author Mohsen Habibi explained
it:
We found that if we use a
certain type of ultrasound with a certain frequency and power, we can create
very local, very focused chemically reactive regions. Basically, the bubbles can be used as
reactors to drive chemical reactions to transform liquid resin into solids or
semi-solids.
The authors believe that DSP can have applications
where AM cannot be used, particularly because sound can penetrate objects that
light cannot (e.g., the human body). Bioprinting
inside the body is not, in itself, new, but has required open surgery, which
DSP would not. “DSP introduces the
possibility of noninvasive deep inside the body printing,” they explicitly
point out.
"Also we can do the repairing of inside
bio-organs. That's a future possibility,” corresponding author Muthukumaran
Packirisamy said. Here’s their video:
I’ve been fascinated with 3D printing for a long time,
especially for its healthcare-related uses (e.g.., prescription
drugs, blood
vessels, prosthetic
devices, even organs),
but tell me we’ll be able to do those noninvasively, using sound waves – well, consider
me entranced.
-------------
All that is cool enough, but ultrasound is being used
for many more healthcare applications, such as destruction of tumors. In fact, that was one of the motivations for
the Concordia efforts; Professor Packirisamy noted:
“Ultrasonic frequencies are already being used in destructive procedures like
laser ablation of tissues and tumours. We wanted to use them to create
something.”
“Focused ultrasound” is the term commonly used; there
is actually a Focused Ultrasound
Foundation. “Focused
ultrasound is a noninvasive therapeutic technology,” Dr. Neal Kassell, founder
and chairman of the Focused Ultrasound Foundation, told
CNN. “We’ve said that focused ultrasound is the most powerful sound
you will never hear, but sound that someday could save your life.”
Some of the uses include:Credit: Focused Ultrasound Foundation
- Earlier this month Canadian surgeons used ultrasound to deliver chemotherapy to an inoperable brain tumor, the first time this has been accomplished. “Focused ultrasound is an innovative and non-invasive approach to more effectively deliver chemotherapy directly to the tumour,” one of the researchers said. “Our hope is that this continued research will bring us closer to enhancing treatments to help change the course of the disease.”
- Focused ultrasound has been shown to be equally effective in pain management and quality of life measures for painful bone metastases as external radiation beam therapy, with low adverse even rates.
- Late last year the FDA approved focused ultrasound to treat the second side of patients with essential tumors; use for the first side was approved in 2016. New research confirmed the long term effectiveness of its use for essential tremors.
- Researchers at UT Southwestern are using high-intensity focused ultrasound to treat medication refractory tremor in essential tremor and tremor-dominant Parkinson’s Disease, which the researchers believe “enables more precise targeting of the brain, decreases treatment times, reduces side effects, and improves treatment response.”
- Researchers at West Virginia University Rockefeller Neuroscience Institute used Low-intensity focused ultrasound (LIFU) in the treatment of Alzheimer’s patients. “This study is also a major step forward for the exciting possibility of combining focused ultrasound with targeted delivery of medications or antibodies that normally have limited capability to cross the blood brain barrier from the blood to the brain.”
- Similarly, researchers at Yonsei University College of
Medicine (South Korea) found
that focused ultrasound improved the delivery of Alzheimer’s drugs by over eight
times. “While there is no complete cure for dementia, we hope that
open BBB [blood brain barrier] surgery using FUS surgery can help give hope to
dementia patients,” the lead researcher said.
- LIFU is showing “promising results” for treatment of major depressive disorder, according to a paper from Delft University. The paper describes LIFU as “an emerging neuromodulation method with disruptive potential since it allows for non-invasive stimulation across the whole brain with milimetre precision.”
- Focused ultrasound has been found safe and effective for intermediate risk prostate cancer.
- A 2020 study suggested that focused ultrasound could be used for patients with depression or obsessive-compulsive disorder. “We demonstrated that FUS is effective in significantly improving symptoms of patients with treatment-resistant OCD and depression,” the lead author said.
That is by no means a complete list. The Focused Ultrasound
Foundation claims
that focused ultrasound is currently (at this writing) being used by 65 device
manufacturers, for 170 clinical indications, in 424 research sites and 895
treatment sites. Impressive numbers, but
still small in the scheme of healthcare. It warns:
Unfortunately,
the evolution of a new therapeutic medical device from concept to standard of
care can take decades. Complicated and inefficient, the process requires the
interaction of many organizations with differing agendas and timelines. There
are also numerous technology, economic, regulatory and reimbursement obstacles
to overcome.
Too often, the mechanisms that healthcare has
developed supposedly to protect us also work against us. As the Foundation also warns: “Decades is too long for patients and
their families to wait for medical breakthroughs.
-----------
Clifford Marks, MD, writes
in The New Yorker about ultrasound replacing the stethoscope, citing
miniaturization, lower costs, and application of AI as factors, but I think he’s
not being ambitious enough. As Diku Mandavia,
MD, told him, “But ultrasound—it’s low-cost, no radiation, has so much value
for patient care . . . it’s going to be ubiquitous.”
Let’s hope so.
No comments:
Post a Comment